252 related articles for article (PubMed ID: 27455771)
1. Novel Long-Circulating Liposomes Consisting of PEG Modified β-Sitosterol for Gambogic Acid Delivery.
Yu F; Tang X
J Nanosci Nanotechnol; 2016 Mar; 16(3):3115-21. PubMed ID: 27455771
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of novel gypenosides long-circulating liposomes consisted by sphingomyelin and beta-sitosterol modified by PEG].
Yu F; Yang JM; Li JJ
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):997-1001. PubMed ID: 24956838
[TBL] [Abstract][Full Text] [Related]
3. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
Zhang J; Chen Y; Li X; Liang X; Luo X
Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
[TBL] [Abstract][Full Text] [Related]
4. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.
Duan Y; Wei L; Petryk J; Ruddy TD
Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312
[TBL] [Abstract][Full Text] [Related]
5. Novel long-circulating liposomes containing peptide library-lipid conjugates: synthesis and in vivo behavior.
Riché EL; Erickson BW; Cho MJ
J Drug Target; 2004 Jul; 12(6):355-61. PubMed ID: 15545085
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
Gao D; Tang S; Tong Q
Int J Nanomedicine; 2012; 7():3517-26. PubMed ID: 22848175
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity.
Kuang Y; Liu J; Liu Z; Zhuo R
Biomaterials; 2012 Feb; 33(5):1596-606. PubMed ID: 22079777
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
9. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
10. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes.
Haeri A; Sadeghian S; Rabbani S; Anvari MS; Lavasanifar A; Amini M; Dadashzadeh S
Int J Pharm; 2013 Oct; 455(1-2):320-30. PubMed ID: 23867987
[TBL] [Abstract][Full Text] [Related]
12. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
Jin SE; Kim IS; Kim CK
Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
[TBL] [Abstract][Full Text] [Related]
14. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
[TBL] [Abstract][Full Text] [Related]
16. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
17. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion.
Yu F; He C; Waddad AY; Munyendo WL; Lv H; Zhou J; Zhang Q
Drug Dev Ind Pharm; 2014 Jun; 40(6):774-82. PubMed ID: 23679668
[TBL] [Abstract][Full Text] [Related]
18. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
19. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
[TBL] [Abstract][Full Text] [Related]
20. Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine.
Zalipsky S; Brandeis E; Newman MS; Woodle MC
FEBS Lett; 1994 Oct; 353(1):71-4. PubMed ID: 7926026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
